Skip to content

Current status and influencing factors of fear of progression in patients with advanced lung cancer

Current status and influencing factors of fear of progression in patients with advanced lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094752
Enrollment
Unknown
Registered
2024-12-26
Start date
2024-08-28
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Trail group:none

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. The clinical pathological diagnosis was primary lung cancer, which met the diagnostic criteria of "Chinese Medical Association Lung Cancer Clinical Diagnosis and Treatment Guideline (2023 edition)" The lung Cancer was staged according to the 8th edition of the Union of International Cancer Control (UICC) staging criteria, and the clinical stage was ? to ?. 3. knowing the condition; 4. able to read and write independently or successfully complete the questionnaire with the help of the researcher; 5. no previous mental illness; 6. informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. Complicated with other malignant tumors or critical diseases; 2. previous mental illness, cognitive or mental disorders; 3. in pregnancy or lactation; 4. severe attention, hearing and speech disorders; 5. refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
Fear of progression;

Secondary

MeasureTime frame
Hope level;Levels of family resilience;

Countries

China

Contacts

Public ContactYin Xiangyi

The First Affiliated Hospital of Army Medical University

1013793966@qq.com+86 17623613887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026